Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1300121
European Journal of Endocrinology, Vol 130, Issue 2, 121-124
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazza, E.
Right arrow Articles by Camanni, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mazza, E.
Right arrow Articles by Camanni, F.

Enhanced adrenocorticotrophic hormone and cortisol responses to corticotrophin-releasing hormone in central idiopathic diabetes insipidus

Enrico Mazza, Stefania Goffi, Paolo Barchi, Emanuela Arvat, Jaele Bellone, Paolo Limone, Ezio Ghigo and Franco Camanni

Mazza E, Goffi S, Barchi P, Arvat E, Bellone J, Limone P, Ghigo E, Camanni F. Enhanced adrenocorticotrophic hormone and cortisol responses to corticotrophin-releasing hormone in central idiopathic diabetes insipidus. Eur J Endocrinol 1994;130:121–4. ISSN 0804–4643

It is well known that arginine vasopressin (AVP) exerts a stimulatory effect on adrenocorticotrophic hormone (ACTH) secretion. Moreover, there is consistent evidence that the hypothalamic AVP-secreting neurons are involved in the neuroregulation of ACTH secretion. With the aim to throw further light on the interaction between AVP and corticotrophin-releasing hormone (CRH) in the neuroregulation of ACTH secretion, in this study we compared the ACTH and cortisol responses to human CRH (100 µg iv as a bolus) in 18 normal subjects (15 females and three males, age 22–35 years) and seven patients with central isolated diabetes insipidus (six females and one male, age 16–40 years). Two patients were newly diagnosed and five had discontinued substitution therapy with desamino-D-AVP 24 h before testing. All had free access to water before and during the test period. The ACTH and cortisol responses to CRH were higher in subjects with diabetes insipidus than in controls, either when evaluated as peak values (ACTH, mean±SEM: 17.0±1.2 vs 7.7±0.7 pmol/l, p=0.0003; cortisol: 611.3±59.4 vs 450.7±21.2 nmol/l, p=0.01) or area under curve values (ACTH: 672.5±75.7 vs 364.0±33.6 pmol·1–1·h–1. p=0.002; cortisol: 29158.0±2937.0 vs 23236.7±1052.1 nmol·l–1 · h–1, p=0.03). These results show that patients with diabetes insipidus have an exaggerated pituitary-adrenal response to CRH. This may be due to the fact that in diabetes insipidus AVP secretion from parvocellular neurons of the paraventricular nucleus in the hypophysial portal system is not impaired. Alternatively, AVP secretion may be defective in both magnocellular and parvocellular hypothalamic AVP-secreting neurons. In this case, it could be hypothesized that adjustment is made to the feedback regulatory mechanisms of the hypothalamic–pituitary–adrenal axis, so that the CRH–ACTH axis assumes a main role with respect to the AVP–ACTH axis.

Franco Camanni, Divisione di Endocrinologia, Ospedale Molinette, corso Dogliotti 14, 10126 Torino. Italy




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
E. Itagaki, S. Ozawa, S. Yamaguchi, K. Ushikawa, T. Tashiro, H. Katahira, M. Takizawa, K. Yoshimoto, S. Murakawa, and H. Ishida
Increases in Plasma ACTH and Cortisol after Hypertonic Saline Infusion in Patients with Central Diabetes Insipidus
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5749 - 5754.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Lacroix, N. N'Diaye, J. Tremblay, and P. Hamet
Ectopic and Abnormal Hormone Receptors in Adrenal Cushing's Syndrome
Endocr. Rev., February 1, 2001; 22(1): 75 - 110.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Pivonello, A. Faggiano, C. Di Somma, M. Klain, M. Filippella, M. Salvatore, G. Lombardi, and A. Colao
Effect of a Short-Term Treatment with Alendronate on Bone Density and Bone Markers in Patients with Central Diabetes Insipidus
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2349 - 2352.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Pivonello, A. Colao, C. Di Somma, G. Facciolli, M. Klain, A. Faggiano, M. Salvatore, and G. Lombardi
Impairment of Bone Status in Patients with Central Diabetes Insipidus
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2275 - 2280.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. L. K. Elias, J. Antunes-Rodrigues, P. C. L. Elias, and A. C. Moreira
Effect of Plasma Osmolality on Pituitary-Adrenal Responses to Corticotropin-Releasing Hormone and Atrial Natriuretic Peptide Changes in Central Diabetes Insipidus
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1243 - 1247.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.